Steroid plaster launched

Patients with steroid-responsive skin disorders have a new treatment option in the form of Betesil.

Each colourless, adhesive 7.5cm x 10cm plaster contains 1.845mg betamethasone, as the valerate salt. Up to six plasters can be applied daily, and treatment may be continued for up to 30 days.

The product is particularly suitable for chronic plaque psoriasis localised in hard-to-treat areas such as the knees and elbows.

View Betesil drug record

Further information: Genus

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

A careful stepwise approach is needed when reducing...

Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome
Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...